LoadingLoadingLoadingThe quick read
Latest quote·Oct 14
No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNeither. Arvinas Inc (ARVN) insiders filed no open-market purchases or sales in the 90 days to Oct 15, 2026, according to SEC Form 4 filings.
None. No member of Congress disclosed a ARVN trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
This summary uses filings available on Oct 15, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position and insiders have been net selling.
Sells/Trims (1)
Point72
$25.0M
trimmed
No tracked top-trader positions in ARVN right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Aug 4, 2026
Period ending
Jun 30, 2026
Adjusted EPS
-$0.28 expected
Revenue
No reported revenue on record
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 4, 2026 | $2.58 / -$0.28Yahoo Finance | +$2.86 beat | Unavailable | Unavailable |
| Mar 31, 2026 | May 11, 2026 | -$0.90 / -$0.96Yahoo Finance | +6.65% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 24, 2026 | -$1.10 / -$0.57Yahoo Finance | -94.32% miss | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 5, 2025 | -$0.48 / -$0.74Yahoo Finance | +35.50% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 6, 2025 | -$0.84 / -$0.89Alpha Vantage | +5.62% beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 1, 2025 | $1.14 / -$0.97Alpha Vantage | +$2.11 beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 11, 2025 | -$0.63 / -$0.96Alpha Vantage | +34.38% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 30, 2024 | -$0.68 / -$0.87Alpha Vantage | +21.84% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $41.9M | $9.5M | $15.6M | $249.7M |
| Cost of what it sold | — | $1.2M | $1.1M | $9.0M |
| Gross profit | $41.9M | $8.3M | $14.5M | $240.7M |
| What it spent | ||||
| Research and development | $64.7M | $61.1M | $60.0M | $52.6M |
| Sales and admin | $21.6M | $22.4M | $19.1M | $24.0M |
| Other operating costs | — | -$3.5M | -$1.9M | — |
| Total operating expenses | $85.7M | $80.0M | $77.2M | $76.6M |
| What was left | ||||
| Operating profit | -$43.8M | -$71.7M | -$62.7M | $164.1M |
| Profit before tax | -$34.8M | -$67.2M | -$57.5M | $169.6M |
| Tax | $300.0K | $200.0K | $100.0K | $200.0K |
| Net profit | -$35.1M | -$67.4M | -$57.6M | $169.4M |
| EBITDA | -$33.5M | -$66.0M | -$56.4M | $159.8M |
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
